Business Wire

Work Connected with the Olympus Scientific Cloud

Jaa

The new Olympus Scientific Cloud expands the capabilities of the EPOCH® 6LT flaw detector and Vanta handheld XRF analyzer at no extra cost, with more features planned in the coming months. A suite of new capabilities, including wireless software updates, easy data backups, and real-time screen sharing for Vanta analyzers help make your work faster and more efficient.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171024005101/en/

Work Connected with the Olympus Scientific Cloud (Photo: Business Wire)

Work Connected with the Olympus Scientific Cloud (Photo: Business Wire)

Olympus is constantly improving the software of our instruments. The Olympus Scientific Cloud (OSC) enables users to wirelessly download the latest software updates directly to their instrument without having to use a PC interface program. When an update for the Vanta analyzer is available, a notification will appear in the device’s user interface, prompting the user to download. EPOCH 6LT users can check the Cloud web application for updates. For fleet managers, this functionality helps ensure that all of the EPOCH 6LT flaw detectors and Vanta analyzers in their fleet are operating on the same software version for reliable, reproducible results.

Once data has been acquired, the Olympus Scientific Cloud makes it easy to back it up and share it with others. Operators can wirelessly upload their data to the Cloud, even while they are still in the field. Users no longer have to worry about maintaining a large backlog of files on their instrument or running out of space. Once the data is in the Cloud, colleagues back in the office or on the other side of the world can see the data for fast, efficient collaboration. The data files can also be transferred in open formats, like CSV, so users can easily access their data using their preferred software.

The OSC has powerful new management functionality. Fleet managers can monitor health parameters of their devices, such as active time, error logs, and temperature.* Managers can also use the OSC to keep track of how much each device is used to help ensure that the work is distributed evenly across the fleet. If an instrument needs to be serviced, the Cloud helps the Olympus service center know what components and software need updating or servicing to minimize downtime.

For Vanta analyzers, the OSC offers additional benefits, including:

  • Screen sharing: users in the field can share their analyzer’s screen with decision-makers back in the office.
  • Advanced fleet management: managers can track the last reported physical location of all of their analyzers.
  • Automatic data uploads: data automatically uploads (or is sent) to the Cloud as soon as you complete a test.

The benefits and functionality of the Olympus Scientific Cloud are paired with leading-edge security features. With a network of data centers located all over the world, users can be assured that their data is stored securely and locally. All data uploaded to the Olympus Scientific Cloud remains the property of the customer; Olympus does not share or use customer data that is stored in the Cloud.

*Health data varies per instrument.

About Olympus

Olympus Corporation operates in industrial, medical, and consumer markets, specializing in optics, electronics, and precision engineering. Olympus is a world-leading manufacturer of innovative test and measurement solutions that are used in industrial and research applications ranging from aerospace, power generation, petrochemical, civil infrastructure, and automotive to consumer products.

For more information about the Olympus Scientific Cloud and Olympus’ full line of nondestructive testing products, contact a sales representative or visit http://www.olympus-ims.com/.

Olympus and EPOCH are registered trademarks, and Vanta is a trademark of Olympus Corporation.

Contact information

Olympus Corporation
Calvin Jory, 781-419-3549
Calvin.Jory@olympus-ossa.com
or
Michelle Wright, 781-419-3664
Michelle.Wright@olympus-ossa.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 12:11Tiedote

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 19:20Tiedote

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 15:31Tiedote

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

Double Win for Vocalink at the 2017 Payments Awards17.11.2017 12:35Tiedote

Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim

Envion AG: Start-up from the Heart of Berlin Has Pioneered Decentralized Mobile Mining by Combining Blockchain with Regenerative Energy17.11.2017 12:00Tiedote

Envion AG has created a technology for the first truly mobile data-center that uses low-priced local energy to mine a broad spectrum of cryptocurrencies (Bitcoin, Ethereum, etc.). By harvesting locally available clean energy right at the source, envion can operate at lower costs than competitors and at the same time reduces the CO2 footprint of the blockchain industry. Envion aims at decentralizing the highly-concentrated mining market (China holds 80% in Bitcoin mining) and at bringing control of the market back to the users. That’s why envion gives 100% of its mining profits back to its community. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171117005011/en/ Envion - World's Most Profitable Standard of Self-Expanding Crypto Infrastructure (Photo: Business Wire) Current challenges in the energy

Chugai's HEMLIBRA® Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors17.11.2017 02:30Tiedote

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the U.S. Food and Drug Administration (FDA) has approved the bispecific antibody emicizumab (US product name: HEMLIBRA®) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. This represents the first regulatory approval for HEMLIBRA® around the world. The US Biologics License Application (BLA) was submitted by Genentech, a member of Roche Group. “We are pleased that HEMLIBRA, a biopharmaceutical created by Chugai scientists based on their exceptional idea, has received its first regulatory approval,” said Chugai’s President & COO, Tatsuro Kosaka. “HEMLIBRA is a first in class biopharmaceutical which is an advancement on the current limited treatment options available for pat

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme